Palisade Bio (PALI) Gains from Investment Securities (2012 - 2026)

Palisade Bio (PALI) has 14 years of Gains from Investment Securities data on file, last reported at $254200.0 in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $254200.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $254200.0 (changed N/A YoY), and the FY2025 annual result was $116600.0, up 130.1% from the prior year.
• Gains from Investment Securities rose to $254200.0 in Q1 2026 per PALI's latest filing, from $89400.0 in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $254200.0 in Q1 2026 and troughed at -$355000.0 in Q4 2022.
• A 4-year average of $34511.5 and a median of $59198.5 in 2023 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities tumbled 79.68% in 2022, then slumped 97.18% in 2023.
• A 4-year view of Gains from Investment Securities shows it stood at -$355000.0 in 2022, then surged by 101.29% to $4576.0 in 2023, then soared by 1853.67% to $89400.0 in 2025, then soared by 184.34% to $254200.0 in 2026.
• Business Quant data shows PALI's Gains from Investment Securities at $254200.0 in Q1 2026, $89400.0 in Q3 2025, and $89400.0 in Q2 2025.